Clinical Trial Details
| Trial ID: | L5640 |
| Source ID: | NCT01990300 |
| Associated Drug: | Alogliptin/Pioglitazone |
| Title: | Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | YES |
| Results: | https://ClinicalTrials.gov/show/NCT01990300/results |
| Conditions: | Type 2 Diabetes Mellitus |
| Interventions: | DRUG: Alogliptin/Pioglitazone |
| Outcome Measures: | Primary: Number of Participants Who Experience at Least One Adverse Events, Up to 12 Months|Changes From Baseline in Glycosylated Hemoglobin (HbA1c), Reported data are changes in HbA1c from baseline at Month 1, 3, 6, 12 and final assessment (up to 12 months)., Baseline and Month 1, 3, 6, 12 and final assessment (up to 12 Months) | Secondary: Changes From Baseline in Fasting Blood Glucose (FBG), Reported data are changes in fasting blood glucose level from baseline at Month 1, 3, 6, 12 and final assessment (up to 12 months)., Baseline and Month 1, 3, 6, 12 and final assessment (up to 12 Months) |
| Sponsor/Collaborators: | Sponsor: Takeda |
| Gender: | ALL |
| Age: | CHILD, ADULT, OLDER_ADULT |
| Phases: | |
| Enrollment: | 3281 |
| Study Type: | OBSERVATIONAL |
| Study Designs: | Observational Model: |Time Perspective: p |
| Start Date: | 2011-11-28 |
| Completion Date: | 2015-03-31 |
| Results First Posted: | 2019-01-18 |
| Last Update Posted: | 2023-09-18 |
| Locations: | Someplace, Japan |
| URL: | https://clinicaltrials.gov/show/NCT01990300 |
